JP Morgan Chase
CLBT icon

JP Morgan Chase’s Cellebrite CLBT Stock Holding History

JP Morgan Chase’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.41M Sell
99,726
-496,874
-83% -$6.57M ﹤0.01% 4438
2026
Q1 		$7.89M Buy
596,600
+474,068
+387% +$7.14M ﹤0.01% 2897
2025
Q4 		$2.21M Sell
122,532
-561,310
-82% -$10.1M ﹤0.01% 3999
2025
Q3 		$12.7M Sell
683,842
-183,531
-21% -$2.88M ﹤0.01% 2514
2025
Q2 		$13.9M Buy
867,373
+300,046
+53% +$5.35M ﹤0.01% 2261
2025
Q1 		$11M Buy
567,327
+235,662
+71% +$4.96M ﹤0.01% 2452
2024
Q4 		$7.31M Sell
331,665
-95,990
-22% -$1.85M ﹤0.01% 3008
2024
Q3 		$7.2M Buy
427,655
+75,092
+21% +$1.11M ﹤0.01% 2910
2024
Q2 		$4.21M Buy
352,563
+120,519
+52% +$1.35M ﹤0.01% 3162
2024
Q1 		$2.57M Buy
232,044
+36,348
+19% +$371K ﹤0.01% 3639
2023
Q4 		$1.69M Buy
195,696
+73,957
+61% +$575K ﹤0.01% 3957
2023
Q3 		$931K Buy
121,739
+66,196
+119% +$497K ﹤0.01% 4110
2023
Q2 		$400K Sell
55,543
-28,470
-34% -$166K ﹤0.01% 4630
2023
Q1 		$512K Buy
84,013
+18,435
+28% +$99.9K ﹤0.01% 4485
2022
Q4 		$286K Buy
65,578
+9,162
+16% +$40.9K ﹤0.01% 4852
2022
Q3 		$221K Sell
56,416
-2,476
-4% -$12.4K ﹤0.01% 4901
2022
Q2 		$301K Buy
58,892
+9,393
+19% +$48.9K ﹤0.01% 4851
2022
Q1 		$317K Buy
49,499
+30,410
+159% +$202K ﹤0.01% 4950
2021
Q4 		$153K Buy
19,089
+5,664
+42% +$53.4K ﹤0.01% 5490
2021
Q3 		$124K Buy
+13,425
New +$140K ﹤0.01% 5464

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

JP Morgan Chase's CLBT Position: Q2 2026 in Review

JP Morgan Chase reduced its Cellebrite (CLBT) stake by 83% in Q2 2026, selling an estimated $6.57M and leaving 99,726 shares worth $1.41M. The position accounts for ﹤0.01% of the portfolio, ranked #4438.

JP Morgan Chase first reported a position in CLBT in Q3 2021 and has held it in 20 quarters since. The position peaked at $13.9M in Q2 2025. 200 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • JP Morgan Chase held 99,726 shares of Cellebrite worth $1.41M as of Q2 2026.
  • JP Morgan Chase sold 496,874 Cellebrite shares in Q2 2026, an estimated $6.57M.
  • Cellebrite made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #4438 holding.
  • JP Morgan Chase first reported a position in Cellebrite in Q3 2021 and has held it in 20 quarters since.
  • JP Morgan Chase's Cellebrite position peaked at $13.9M in Q2 2025.
  • 200 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.